The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Ultra-large Volume Wearable Injectors-Global Market Insights and Sales Trends 2025

Ultra-large Volume Wearable Injectors-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1822160

No of Pages : 105

Ask Your Query
Synopsis
Ultra-large volume wearable injectors are a new innovation within the injectable drug delivery market. These injectors are used to deliver large (>1-2 mL) volumes of drugs to drug developers, clinicians, and patients.
The global Ultra-large Volume Wearable Injectors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ultra-large Volume Wearable Injectors in various end use industries. The expanding demands from the Hospitals, Clinics, Home Care Settings and Others, are propelling Ultra-large Volume Wearable Injectors market. On-Body Injectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Off-Body Injectors segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Ultra-large Volume Wearable Injectors market, driven by demand from China, the second largest economy with some signs of stabilising, the Ultra-large Volume Wearable Injectors market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ultra-large Volume Wearable Injectors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ultra-large Volume Wearable Injectors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ultra-large Volume Wearable Injectors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ultra-large Volume Wearable Injectors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ultra-large Volume Wearable Injectors covered in this report include Ypsomed, Amgen, West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical, BD Medical, Enable Injections and Sorrel Medical, etc.
The global Ultra-large Volume Wearable Injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ypsomed
Amgen
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical
BD Medical
Enable Injections
Sorrel Medical
E3D Elcam Drug Delivery Devices
Global Ultra-large Volume Wearable Injectors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ultra-large Volume Wearable Injectors market, Segment by Type:
On-Body Injectors
Off-Body Injectors
Global Ultra-large Volume Wearable Injectors market, by Application
Hospitals
Clinics
Home Care Settings
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ultra-large Volume Wearable Injectors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ultra-large Volume Wearable Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Ultra-large Volume Wearable Injectors Market Overview
1.1 Ultra-large Volume Wearable Injectors Product Overview
1.2 Ultra-large Volume Wearable Injectors Market Segment by Type
1.2.1 On-Body Injectors
1.2.2 Off-Body Injectors
1.3 Global Ultra-large Volume Wearable Injectors Market Size by Type
1.3.1 Global Ultra-large Volume Wearable Injectors Market Size Overview by Type (2018-2029)
1.3.2 Global Ultra-large Volume Wearable Injectors Historic Market Size Review by Type (2018-2023)
1.3.3 Global Ultra-large Volume Wearable Injectors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ultra-large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
1.4.2 Europe Ultra-large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Ultra-large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Ultra-large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Ultra-large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
2 Global Ultra-large Volume Wearable Injectors Market Competition by Company
2.1 Global Top Players by Ultra-large Volume Wearable Injectors Sales (2018-2023)
2.2 Global Top Players by Ultra-large Volume Wearable Injectors Revenue (2018-2023)
2.3 Global Top Players by Ultra-large Volume Wearable Injectors Price (2018-2023)
2.4 Global Top Manufacturers Ultra-large Volume Wearable Injectors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ultra-large Volume Wearable Injectors Market Competitive Situation and Trends
2.5.1 Ultra-large Volume Wearable Injectors Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Ultra-large Volume Wearable Injectors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ultra-large Volume Wearable Injectors as of 2022)
2.7 Date of Key Manufacturers Enter into Ultra-large Volume Wearable Injectors Market
2.8 Key Manufacturers Ultra-large Volume Wearable Injectors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ultra-large Volume Wearable Injectors Status and Outlook by Region
3.1 Global Ultra-large Volume Wearable Injectors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Ultra-large Volume Wearable Injectors Historic Market Size by Region
3.2.1 Global Ultra-large Volume Wearable Injectors Sales in Volume by Region (2018-2023)
3.2.2 Global Ultra-large Volume Wearable Injectors Sales in Value by Region (2018-2023)
3.2.3 Global Ultra-large Volume Wearable Injectors Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Ultra-large Volume Wearable Injectors Forecasted Market Size by Region
3.3.1 Global Ultra-large Volume Wearable Injectors Sales in Volume by Region (2024-2029)
3.3.2 Global Ultra-large Volume Wearable Injectors Sales in Value by Region (2024-2029)
3.3.3 Global Ultra-large Volume Wearable Injectors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Ultra-large Volume Wearable Injectors by Application
4.1 Ultra-large Volume Wearable Injectors Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Home Care Settings
4.1.4 Others
4.2 Global Ultra-large Volume Wearable Injectors Market Size by Application
4.2.1 Global Ultra-large Volume Wearable Injectors Market Size Overview by Application (2018-2029)
4.2.2 Global Ultra-large Volume Wearable Injectors Historic Market Size Review by Application (2018-2023)
4.2.3 Global Ultra-large Volume Wearable Injectors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ultra-large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
4.3.2 Europe Ultra-large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Ultra-large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Ultra-large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Ultra-large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
5 North America Ultra-large Volume Wearable Injectors by Country
5.1 North America Ultra-large Volume Wearable Injectors Historic Market Size by Country
5.1.1 North America Ultra-large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Ultra-large Volume Wearable Injectors Sales in Volume by Country (2018-2023)
5.1.3 North America Ultra-large Volume Wearable Injectors Sales in Value by Country (2018-2023)
5.2 North America Ultra-large Volume Wearable Injectors Forecasted Market Size by Country
5.2.1 North America Ultra-large Volume Wearable Injectors Sales in Volume by Country (2024-2029)
5.2.2 North America Ultra-large Volume Wearable Injectors Sales in Value by Country (2024-2029)
6 Europe Ultra-large Volume Wearable Injectors by Country
6.1 Europe Ultra-large Volume Wearable Injectors Historic Market Size by Country
6.1.1 Europe Ultra-large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Ultra-large Volume Wearable Injectors Sales in Volume by Country (2018-2023)
6.1.3 Europe Ultra-large Volume Wearable Injectors Sales in Value by Country (2018-2023)
6.2 Europe Ultra-large Volume Wearable Injectors Forecasted Market Size by Country
6.2.1 Europe Ultra-large Volume Wearable Injectors Sales in Volume by Country (2024-2029)
6.2.2 Europe Ultra-large Volume Wearable Injectors Sales in Value by Country (2024-2029)
7 Asia-Pacific Ultra-large Volume Wearable Injectors by Region
7.1 Asia-Pacific Ultra-large Volume Wearable Injectors Historic Market Size by Region
7.1.1 Asia-Pacific Ultra-large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Ultra-large Volume Wearable Injectors Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Ultra-large Volume Wearable Injectors Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Ultra-large Volume Wearable Injectors Forecasted Market Size by Region
7.2.1 Asia-Pacific Ultra-large Volume Wearable Injectors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Ultra-large Volume Wearable Injectors Sales in Value by Region (2024-2029)
8 Latin America Ultra-large Volume Wearable Injectors by Country
8.1 Latin America Ultra-large Volume Wearable Injectors Historic Market Size by Country
8.1.1 Latin America Ultra-large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Ultra-large Volume Wearable Injectors Sales in Volume by Country (2018-2023)
8.1.3 Latin America Ultra-large Volume Wearable Injectors Sales in Value by Country (2018-2023)
8.2 Latin America Ultra-large Volume Wearable Injectors Forecasted Market Size by Country
8.2.1 Latin America Ultra-large Volume Wearable Injectors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Ultra-large Volume Wearable Injectors Sales in Value by Country (2024-2029)
9 Middle East and Africa Ultra-large Volume Wearable Injectors by Country
9.1 Middle East and Africa Ultra-large Volume Wearable Injectors Historic Market Size by Country
9.1.1 Middle East and Africa Ultra-large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Ultra-large Volume Wearable Injectors Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Ultra-large Volume Wearable Injectors Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Ultra-large Volume Wearable Injectors Forecasted Market Size by Country
9.2.1 Middle East and Africa Ultra-large Volume Wearable Injectors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Ultra-large Volume Wearable Injectors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Ypsomed
10.1.1 Ypsomed Company Information
10.1.2 Ypsomed Introduction and Business Overview
10.1.3 Ypsomed Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Ypsomed Ultra-large Volume Wearable Injectors Products Offered
10.1.5 Ypsomed Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Amgen Ultra-large Volume Wearable Injectors Products Offered
10.2.5 Amgen Recent Development
10.3 West Pharmaceuticals
10.3.1 West Pharmaceuticals Company Information
10.3.2 West Pharmaceuticals Introduction and Business Overview
10.3.3 West Pharmaceuticals Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 West Pharmaceuticals Ultra-large Volume Wearable Injectors Products Offered
10.3.5 West Pharmaceuticals Recent Development
10.4 Unilife Corporation
10.4.1 Unilife Corporation Company Information
10.4.2 Unilife Corporation Introduction and Business Overview
10.4.3 Unilife Corporation Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Unilife Corporation Ultra-large Volume Wearable Injectors Products Offered
10.4.5 Unilife Corporation Recent Development
10.5 CeQur
10.5.1 CeQur Company Information
10.5.2 CeQur Introduction and Business Overview
10.5.3 CeQur Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CeQur Ultra-large Volume Wearable Injectors Products Offered
10.5.5 CeQur Recent Development
10.6 Sensile Medical
10.6.1 Sensile Medical Company Information
10.6.2 Sensile Medical Introduction and Business Overview
10.6.3 Sensile Medical Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sensile Medical Ultra-large Volume Wearable Injectors Products Offered
10.6.5 Sensile Medical Recent Development
10.7 BD Medical
10.7.1 BD Medical Company Information
10.7.2 BD Medical Introduction and Business Overview
10.7.3 BD Medical Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.7.4 BD Medical Ultra-large Volume Wearable Injectors Products Offered
10.7.5 BD Medical Recent Development
10.8 Enable Injections
10.8.1 Enable Injections Company Information
10.8.2 Enable Injections Introduction and Business Overview
10.8.3 Enable Injections Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Enable Injections Ultra-large Volume Wearable Injectors Products Offered
10.8.5 Enable Injections Recent Development
10.9 Sorrel Medical
10.9.1 Sorrel Medical Company Information
10.9.2 Sorrel Medical Introduction and Business Overview
10.9.3 Sorrel Medical Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sorrel Medical Ultra-large Volume Wearable Injectors Products Offered
10.9.5 Sorrel Medical Recent Development
10.10 E3D Elcam Drug Delivery Devices
10.10.1 E3D Elcam Drug Delivery Devices Company Information
10.10.2 E3D Elcam Drug Delivery Devices Introduction and Business Overview
10.10.3 E3D Elcam Drug Delivery Devices Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.10.4 E3D Elcam Drug Delivery Devices Ultra-large Volume Wearable Injectors Products Offered
10.10.5 E3D Elcam Drug Delivery Devices Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ultra-large Volume Wearable Injectors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ultra-large Volume Wearable Injectors Industrial Chain Analysis
11.4 Ultra-large Volume Wearable Injectors Market Dynamics
11.4.1 Ultra-large Volume Wearable Injectors Industry Trends
11.4.2 Ultra-large Volume Wearable Injectors Market Drivers
11.4.3 Ultra-large Volume Wearable Injectors Market Challenges
11.4.4 Ultra-large Volume Wearable Injectors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ultra-large Volume Wearable Injectors Distributors
12.3 Ultra-large Volume Wearable Injectors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock